Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes

Table 2

Exposure to immunosuppressants before diagnosis of PCP.

Immunosuppressants	N = 50
CTX	24 (48%)
CsA	10 (20%)
MMF	4 (8%)
FK506	2 (4%)
MTX	1 (2%)
TwHF	1 (2%)
LEF	1 (2%)
CTX + CsA	3 (6%)
CTX + TwHF	2 (4%)
CTX + MMF	1 (2%)
CTX + HCQ	1 (2%)

CTX: cyclophosphamide, CsA: cyclosporine A, MMF: mycophenolate mofetil, FK506: tacrolimus, MTX: methotrexate, TwHF: tripterygium wilfordii hook F, LEF: leflunomide, and HCQ: hydroxychloroquine. Data were presented as numbers (%).